Skip to content

Clinical trials

Phase 3 Retinopathy of Prematurity trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Retinopathy of Prematurity Phase: Phase 3 Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20051
20081
20131
20141
20151
20161
20192
20203
20221
20232

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed13
Terminated2
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bayer2
NICHD Neonatal Research Network2
Novartis Pharmaceuticals2
Alexandria University1
Assaf-Harofeh Medical Center1
Cairo University1
Carola Pfeiffer-Mosesson1
Jaeb Center for Health Research1
McMaster University1
Nabeel Ali1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Retinopathy of Prematurity16
Premature Birth4
Bronchopulmonary Dysplasia2
Infant, Newborn, Diseases2
Pain2
Agnosia1
Anemia1
Hydrocephalus1
Leukomalacia, Periventricular1
Retinal Diseases1

Trials

Showing 51 to 16 of 16. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.